Index by author

February 01, 2020; Volume 87, Issue 2

    Amy L. Pasternak

  • Pharmacogenomics: An evolving clinical tool for precision medicine

    Jennifer K. Hockings, PharmD, PhD, Amy L. Pasternak, PharmD, Angelika L. Erwin, MD, PhD, Neil T. Mason, MBA, Charis Eng, MD, PhD and J. Kevin Hicks, PharmD, PhD
    • Cleveland Clinic Journal of Medicine February 2020, 87 (2) 91-99;
    • DOI: https://doi.org/10.3949/ccjm.87a.19073
    • More than 90% of patients are thought to carry at least 1 genetic variant that should prompt a change in dosing or medication.

  • Angelika L. Erwin

  • Pharmacogenomics: An evolving clinical tool for precision medicine

    Jennifer K. Hockings, PharmD, PhD, Amy L. Pasternak, PharmD, Angelika L. Erwin, MD, PhD, Neil T. Mason, MBA, Charis Eng, MD, PhD and J. Kevin Hicks, PharmD, PhD
    • Cleveland Clinic Journal of Medicine February 2020, 87 (2) 91-99;
    • DOI: https://doi.org/10.3949/ccjm.87a.19073
    • More than 90% of patients are thought to carry at least 1 genetic variant that should prompt a change in dosing or medication.

  • Brian F. Mandell

  • The search for precision

    Brian F. Mandell, MD, PhD
    • Cleveland Clinic Journal of Medicine February 2020, 87 (2) 71-72;
    • DOI: https://doi.org/10.3949/ccjm.87b.02020
    • The day may come soon when we get EMR alerts if we try to prescribe certain drugs to patients with certain gene variants.

  • Byron J. Hoogwerf

  • Type of diabetes mellitus: Does it matter to the clinician?

    Byron J. Hoogwerf, MD, FACP, FACE
    • Cleveland Clinic Journal of Medicine February 2020, 87 (2) 100-108;
    • DOI: https://doi.org/10.3949/ccjm.87a.19020
    • Understanding the many faces of diabetes can make a difference in how clinicians select glucose-lowering therapy.

  • C. John Sperati

  • A young man with hypertension and hypokalemia

    Zainah Chiko, BSHS, Mohamad Hanouneh, MD and C. John Sperati, MD, MHS
    • Cleveland Clinic Journal of Medicine February 2020, 87 (2) 77-79;
    • DOI: https://doi.org/10.3949/ccjm.87a.19111
    • At presentation, his blood pressure was 184/154 mm Hg, and his serum potassium level was 3.1 mmol/L.

  • Charis Eng

  • Pharmacogenomics: An evolving clinical tool for precision medicine

    Jennifer K. Hockings, PharmD, PhD, Amy L. Pasternak, PharmD, Angelika L. Erwin, MD, PhD, Neil T. Mason, MBA, Charis Eng, MD, PhD and J. Kevin Hicks, PharmD, PhD
    • Cleveland Clinic Journal of Medicine February 2020, 87 (2) 91-99;
    • DOI: https://doi.org/10.3949/ccjm.87a.19073
    • More than 90% of patients are thought to carry at least 1 genetic variant that should prompt a change in dosing or medication.

  • Claudio Milstein

  • A cough that won’t go away: Evaluation and treatment in 2 patients

    Maxwell Y. Lee, BS, Rachel M. Taliercio, DO, Michelle Adessa, MS, CCC-SLP, Claudio Milstein, PhD and Paul C. Bryson, MD
    • Cleveland Clinic Journal of Medicine February 2020, 87 (2) 83-89;
    • DOI: https://doi.org/10.3949/ccjm.87a.19010
    • Two patients present with similar symptoms, but different causes and treatment.

  • Haitham M. Ahmed

  • TOC Icon

    Familial hypercholesterolemia: Detect, treat, and ask about family

    Nishant P. Shah, MD, Haitham M. Ahmed, MD, MPH and W. H. Wilson Tang, MD
    • Cleveland Clinic Journal of Medicine February 2020, 87 (2) 109-120;
    • DOI: https://doi.org/10.3949/ccjm.87a.19021
    • Patients can develop elevated LDL-C and atherosclerotic cardiovascular disease at a young age.

  • J. Kevin Hicks

  • Pharmacogenomics: An evolving clinical tool for precision medicine

    Jennifer K. Hockings, PharmD, PhD, Amy L. Pasternak, PharmD, Angelika L. Erwin, MD, PhD, Neil T. Mason, MBA, Charis Eng, MD, PhD and J. Kevin Hicks, PharmD, PhD
    • Cleveland Clinic Journal of Medicine February 2020, 87 (2) 91-99;
    • DOI: https://doi.org/10.3949/ccjm.87a.19073
    • More than 90% of patients are thought to carry at least 1 genetic variant that should prompt a change in dosing or medication.

  • Jennifer K. Hockings

  • Pharmacogenomics: An evolving clinical tool for precision medicine

    Jennifer K. Hockings, PharmD, PhD, Amy L. Pasternak, PharmD, Angelika L. Erwin, MD, PhD, Neil T. Mason, MBA, Charis Eng, MD, PhD and J. Kevin Hicks, PharmD, PhD
    • Cleveland Clinic Journal of Medicine February 2020, 87 (2) 91-99;
    • DOI: https://doi.org/10.3949/ccjm.87a.19073
    • More than 90% of patients are thought to carry at least 1 genetic variant that should prompt a change in dosing or medication.

Previous